EUVIMEDEUVIMED entdecken
Crossref

Cytomegalovirus Infection Risk Factors in Allogeneic Hematopoietic Stem Cell Transplantation Can Defibrotide Be a Risk Factor?

Lecturer Zeynep Burçin Yılmaz, Funda Memişoğlu, Emine Hidayet, İrfan Kuku, Mehmet Ali Erkurt, Emin Kaya, İlhami Berber

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.05.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Lecturer Zeynep Burçin Yılmaz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases and Clinical Microbiology Department, Inonu University, Malatya, Turkiye. Electronic address: zeynep_yilmaz_burcin@hotmail.com. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation, Polydeoxyribonucleotides. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND PURPOSE: Cytomegalovirus (CMV) infection is a prevalent complication, affecting 30% to 50% of patients following Allogeneic Hematopoietic Stem Cell Transplantation (allo-AHCT). This study aims to investigate the risk factors contributing to CMV infection development. MATERIALS AND METHODS: A retrospective analysis was performed on 196 patients with hematological malignancies who underwent allo-HSCT in the Stem Cell Transplantation Unit of Inonu University Faculty of Medicine over a 5-year period. Propensity scores were calculated by matching 1:1 for gender and age variables in individuals with CMV infection and in the control group. RESULTS: Of the 196 patients included in the study, 75 (38.3 %) were female and 121 (61.7 %) were male. According to univariate analysis, CMV infection was seen more frequently in ALL patients than in AML patients (p = .012), while the conditioning regimen (p = 1) did not affect the outcome in terms of risk. Blood cyclosporine levels measured simultaneously with CMV positivity were significant in terms of risk (p = .006). A significant correlation was found between GvHD and CMV infection (p < .001). According to multivariate analysis, receiving defibrotide for VOD prophylaxis posed a risk for CMV positivity. CONCLUSION: In our study, only defibrotide prophylaxis was noted as a risk factor in multivariate analysis. While there are ongoing studies for the use of defibrotide in GVHD prophylaxis, more studies are needed to say that it is a definite risk factor for CMV. We believe that focusing on prophylactic treatments used during the transplantation process will be guiding in determining risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantationPolydeoxyribonucleotidesHumansMaleFemaleRisk FactorsRetrospective StudiesAdultMiddle AgedTransplantation, HomologousAdolescentYoung AdultCyclosporineGraft vs Host Disease

Substanzen

PolydeoxyribonucleotidesdefibrotideCyclosporine

Autor:innen und Institutionen

  • Infectious Diseases and Clinical Microbiology Department, Inonu University, Malatya, Turkiye. Electronic address: zeynep_yilmaz_burcin@hotmail.com.
  • Infectious Diseases and Clinical Microbiology Department, Inonu University, Malatya, Turkiye.
  • Internal Medicine, Department of Hematology, Inonu University, Malatya, Turkiye.

Zitieren

APA

Yılmaz, L. Z. B., Memişoğlu, F., Hidayet, E., Kuku, İ., Erkurt, M. A., Kaya, E., & Berber, İ. (2025). Cytomegalovirus Infection Risk Factors in Allogeneic Hematopoietic Stem Cell Transplantation Can Defibrotide Be a Risk Factor?. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.05.018

Vancouver

Yılmaz LZB, Memişoğlu F, Hidayet E, Kuku İ, Erkurt MA, Kaya E, et al. Cytomegalovirus Infection Risk Factors in Allogeneic Hematopoietic Stem Cell Transplantation Can Defibrotide Be a Risk Factor?. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.05.018

BibTeX
@article{Ylmaz2025,
  author = {Yılmaz, Lecturer Zeynep Burçin and Memişoğlu, Funda and Hidayet, Emine and Kuku, İrfan and Erkurt, Mehmet Ali and Kaya, Emin and Berber, İlhami},
  title = {Cytomegalovirus Infection Risk Factors in Allogeneic Hematopoietic Stem Cell Transplantation Can Defibrotide Be a Risk Factor?},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.05.018}
}
Kostenlos starten →